109 related articles for article (PubMed ID: 9673440)
1. Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation.
van den Buuse M; Wilks DP; Cornish JL
Clin Exp Pharmacol Physiol; 1998; 25(7-8):624-6. PubMed ID: 9673440
[TBL] [Abstract][Full Text] [Related]
2. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats.
Cornish JL; Wilks DP; Van den Buuse M
Neuroscience; 1997 Nov; 81(1):69-78. PubMed ID: 9300402
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
Cornish JL; van den Buuse M
Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.
van Den Buuse M; Catanzariti R
Br J Pharmacol; 2000 Jan; 129(1):29-36. PubMed ID: 10694199
[TBL] [Abstract][Full Text] [Related]
5. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.
van den Buuse M
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):661-8. PubMed ID: 9750953
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
Altier N; Stewart J
J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
Hagan RM; Jones BJ; Jordan CC; Tyers MB
Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
[TBL] [Abstract][Full Text] [Related]
8. Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system.
Cornish JL; van den Buuse M
Neurosci Lett; 1994 Aug; 176(2):142-6. PubMed ID: 7530350
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
[TBL] [Abstract][Full Text] [Related]
10. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.
Placenza FM; Fletcher PJ; Rotzinger S; Vaccarino FJ
Psychopharmacology (Berl); 2004 Dec; 177(1-2):111-20. PubMed ID: 15167979
[TBL] [Abstract][Full Text] [Related]
11. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
[TBL] [Abstract][Full Text] [Related]
13. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain.
Altier N; Stewart J
Brain Res; 1993 Nov; 628(1-2):279-85. PubMed ID: 7508809
[TBL] [Abstract][Full Text] [Related]
14. Regional expression of c-fos in rat brain following stimulation of the ventral tegmental area.
Cornish JL; van den Buuse M
Neurosci Lett; 1996 Dec; 220(1):17-20. PubMed ID: 8977138
[TBL] [Abstract][Full Text] [Related]
15. Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions.
Eison AS; Iversen SD; Sandberg BE; Watson SP; Hanley MR; Iversen LL
Science; 1982 Jan; 215(4529):188-90. PubMed ID: 6171884
[TBL] [Abstract][Full Text] [Related]
16. Prolonged central effects of quinpirole on cardiovascular regulation.
van den Buuse M; Morton SJ; Cornish JL; Head GA
J Pharmacol Exp Ther; 1996 Apr; 277(1):473-83. PubMed ID: 8613956
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
Altier N; Stewart J
Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
[TBL] [Abstract][Full Text] [Related]
18. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
Eison AS; Eison MS; Iversen SD
Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
Boix F; Huston JP; Schwarting RK
Brain Res; 1992 Oct; 592(1-2):181-6. PubMed ID: 1280516
[TBL] [Abstract][Full Text] [Related]
20. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
